Article Details
Retrieved on: 2021-01-04 09:03:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Under the terms of the agreement, AstraZeneca has received a payment of $250 million from Cheplapharm and will receive further non-contingent ...
Article found on: www.sharesmagazine.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here